Product Name | Ziconotide Acetate | Sequence | H-Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-
Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-
Gly-Lys-Cys-NH2
Cys1-Cys16， Cys8-Cys20， Cys15-Cys25 | Cas No. | 107452-89-1 | Molecular Formula | C102H172N36O32S7 | Molecular Weight | 2639.18 | Purity (HPLC) | 98%min. | Appearance | White powder | Single Impurity (HPLC) | 1.0%max | Amino Acid Composition | ±10% of theoretical | Peptide Content (N%) | ≥80.0% | Water Content(Karl Fischer) | ≤6.0% | Acetate Content (HPIC) | ≤12.0% | MS(ESI) | Consistent | Mass Balance | 95.0~105.0% | | | |
|
|
|
|
With more than 20 years of experience in solid-phase peptide synthesis, SBS Genetech is recognized as one of the global major leading industry players in Peptide Synthesis by third-party market researchers. For more details, please visit Peptide Synthesis Market 2017-2022 International Outlook, Trends and Analysis.
Only for research and not intended for treatment of humans or animals
